Insider Selling: eHealth (NASDAQ:EHTH) Director Sells $39,161.85 in Stock

eHealth, Inc. (NASDAQ:EHTH) Director Francis Soistman, Jr. sold 37,297 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $1.05, for a total value of $39,161.85. Following the transaction, the director directly owned 1,015,221 shares in the company, valued at $1,065,982.05. The trade was a 3.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

eHealth Stock Up 4.1%

EHTH opened at $0.99 on Friday. The stock’s fifty day simple moving average is $1.35 and its 200 day simple moving average is $1.52. eHealth, Inc. has a 1-year low of $0.90 and a 1-year high of $5.89. The stock has a market cap of $31.69 million, a PE ratio of -0.85 and a beta of 1.51. The company has a current ratio of 5.12, a quick ratio of 5.12 and a debt-to-equity ratio of 0.21.

eHealth (NASDAQ:EHTH) last released its quarterly earnings data on Tuesday, August 4th. The financial services provider reported ($1.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.84) by ($0.34). eHealth had a return on equity of 6.13% and a net margin of 5.42%.The company had revenue of $33.57 million for the quarter, compared to the consensus estimate of $33.28 million. As a group, research analysts expect that eHealth, Inc. will post 0.8 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Royal Bank Of Canada reduced their target price on shares of eHealth from $3.00 to $2.00 and set a “sector perform” rating for the company in a report on Tuesday, August 25th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $3.00 price objective on shares of eHealth in a research report on Friday, May 8th. Weiss Ratings restated a “sell (d)” rating on shares of eHealth in a report on Thursday, August 13th. Finally, UBS Group decreased their target price on eHealth from $2.00 to $1.75 and set a “neutral” rating on the stock in a research report on Wednesday, August 5th. Five investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, eHealth presently has an average rating of “Reduce” and an average target price of $2.19.

Hedge Funds Weigh In On eHealth

Institutional investors and hedge funds have recently modified their holdings of the business. Palo Alto Investors LP acquired a new stake in eHealth in the 2nd quarter worth about $2,209,368. Nantahala Capital Management LLC acquired a new stake in shares of eHealth in the second quarter valued at approximately $2,624,547. Ieq Capital LLC acquired a new stake in shares of eHealth in the second quarter valued at approximately $107,000. Callan Family Office LLC bought a new stake in shares of eHealth in the second quarter valued at approximately $26,000. Finally, Cetera Investment Advisers bought a new stake in shares of eHealth in the first quarter valued at approximately $27,000. 79.54% of the stock is currently owned by institutional investors and hedge funds.

About eHealth

eHealth, Inc operates one of the largest online private health insurance exchanges in the United States. The company’s platform enables consumers to compare, select and enroll in individual, family and small-group health insurance plans offered by a broad network of licensed insurance carriers. In addition to Affordable Care Act–compliant offerings, eHealth provides dedicated services for Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans, helping seniors navigate the complexities of Medicare coverage.

Through its digital marketplace, eHealth delivers real-time quotes, detailed plan comparisons and enrollment processing.